Searched for
GENERIC OPHTHALMIC SOLUTION
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some not- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 33%
- Dr Reddy's launches generic OTC ophthalmic solution in US marketDr Reddy's Laboratories has launched a new eye drop in the United States. This over-the-counter solution treats itchy eyes. It is an antihi...14 Jan, 2026, 10.51 PM IST
- Glenmark launches generic ophthalmic solution in US marketGlenmark Pharmaceuticals' subsidiary has introduced Latanoprost ophthalmic solution, a generic medication for glaucoma, in the US market. T...14 Feb, 2025, 10.07 AM IST
- Glenmark launches generic glaucoma treatment ophthalmic solutionGlenmark Pharmaceuticals Inc., USA launched a generic version of Travatan Z, a glaucoma treatment, called Travoprost ophthalmic solution (0...27 Nov, 2024, 10.42 AM IST
- Dr Reddy's, FDC recall products in US for manufacturing issuesDr Reddy's Laboratories and FDC Ltd issued voluntary recalls for medications in the US market due to manufacturing defects. Dr Reddy's reca...17 Nov, 2024, 11.45 AM IST
- Alembic Pharma gets USFDA nod for generic Bromfenac ophthalmic solutionAlembic Pharmaceuticals Ltd has obtained final approval from the US FDA for its generic Bromfenac ophthalmic solution, used to treat postop...10 Jul, 2024, 05.07 PM IST
- Lupin gets USFDA nod for Bromfenac Ophthalmic SolutionPharma major Lupin on Wednesday said it has received approval from the US health regulator to market its generic Bromfenac Ophthalmic Solut...16 Aug, 2023, 03.52 PM IST
- Midcap stock zooms 9% on receiving USFDA approval for glaucoma drugBrimonidine Tartrate Ophthalmic Solution is an alpha-adrenergic receptor agonist indicated for the reduction of elevated intraocular pressu...31 Mar, 2023, 01.38 PM IST
- Dr Reddy's Laboratories launches over-the-counter eye allergy drop in USDr Reddy's said Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2 per cent and 0.1 per cent, are indicated for the temporary relief of...17 Sep, 2020, 12.29 PM IST
- Alembic gets USFDA nod for generic ophthalmic solutionAlembic Pharmaceuticals on Monday said it has received approval from the US health regulator to market Alcaftadine ophthalmic solution, in ...20 Apr, 2020, 12.46 PM IST
- Alembic Pharma gets USFDA nod for 2 generic productsThe product is generic version of Sanofi-Aventis US LLC's Aubagio tablets in the same strengths.22 Apr, 2019, 03.13 PM IST
- Local pharma formulators to benefit from new USFDA generic guidance: ReportThis will help domestic pharma formulators with pending ANDA approvals to reduce review cycles and expedite approvals, says a weekend repor...28 Oct, 2018, 12.27 PM IST
- Lupin gains 4% on drug launch in USVigamox had US sales of USD 267.9 million (IMS MAT March 2017), the report added.07 Jul, 2017, 04.32 PM IST
- Lupin launches generic conjunctivitis treatment medicine in USThe product is produced at Lupin's Pithampur manufacturing facility, it added. The medicine is generic equivalent of Novartis Corp's Vigamo...05 Jul, 2017, 02.27 PM IST
- Sun Pharma gets USFDA nod for eye inflammation drugThe company is likely to commercialise BromSite through its newly formed US-based division Sun Ophthalmics in the second half of 2016.10 Apr, 2016, 01.45 PM IST
- Aurobindo Pharma gets USFDA nod for its conjunctivitis drugAurobindo Pharma has received approval from the USFDA nod for generic Olopatadine Hydrochloride ophthalmic solution used for treatment of c...22 Dec, 2015, 01.13 PM IST
- Lupin pharma gets USFDA nod to market ophthalmic solutionThe company said it has received the final approval for its product, a generic version of Allergan Inc's Lumigan Ophthalmic Solution, from ...23 Feb, 2015, 03.52 PM IST
- Lupin launches generic ophthalmic solution in US marketLupin launched generic version of Allergan Inc's Zymaxid Ophthalmic Solution in US market with 180 days of marketing exclusivity.03 Oct, 2013, 11.27 AM IST
Load More
